Meytav  
 
 
 
 
 
Contact Details:
Mr Arie Amara
972-52-345-7753
arie@helixbus.com

Helix

 
Status
The Company was established in mid-2004 with seed funding provided by the Meytav incubator and private investors. The Company completed development and production of its CBUS for diagnostic prototype and is now undergoing clinical evaluation in several major hospitals.
Sector and Field of Activity
Medical imaging devices for cancer diagnosis and treatment. Technological field of Health Care and Diagnostics.
 
Underlying Science and Technology
Helix Medical Systems Ltd. is an Israeli medical company developing innovative medical imaging devices for cancer diagnosis and treatment.

The company's first product is the Circular Breast Ultrasound Scanner (CBUS). The CBUS is an automated system that provides high quality MPR images of the breast. It produces ultrasonic images by acquiring circular, or helical, sets of data of the entire breast. These images undergo a process of reconstruction and volume rendering
of the data in order to produce a single ultrasonic image. The reconstructed image shows diagnostic information of the complete volume of the breast tissue.
 
The CBUS device can be used with existing ultrasound systems; therefore, the user does not need to learn a new system or change the imaging style. Most women’s clinics
have ultrasound systems whose users are proficient with their user interface, and are used to the image quality, style, and "feel". The CBUS device augments the existing system and does not change the operation, control or the image appearance of the existing ultrasound system.

The Company’s aim is to provide a complete solution both diagnostic and therapeutic that will significantly shorten the present "freehand" procedure's time (including set-up) and increase patient throughput. The results will be increased clinic revenue (easy to justify ROI) and improved patient comfort. Ultimately, the design allows for access to the entire breast in the same orientation and relation of probe-to-needle as presently used by physicians. The CBUS device includes disposable components that ensure ongoing utilization of the installed base.

In addition to 2D standard imaging, the CBUS provides an enhanced MPR image on its auxiliary monitor. This image takes advantage of the multiple sampling of the breast during the tomographic scan, resulting in superior sensitivity, and in improved signal to noise ratio and resolution.
Team – Management and Board of Directors
Mr. Arie Amara - CEO, 
Mr. Ron Hadani - Member of the Board of Directors
Mr. Avi Amara - Member of the Board of Directors
Mr. Larry Krauss - Member of the Board of Directors
Mr. Lothar Koob - Member of the Board of Directors
Mr. Dan Zeeli - Member of the Board of Directors
 
A Meytav Portfolio Company, Contact Us >> Print >>
Back to Top >>
 
Angio B
Endogun
SpearCast
Collplant
UC Care
Orbix Medical Ltd
Novotyr therapeutics
Braintact
BioMagnesium
FlexSIS
Protea
Surgical Structure
Quinova Rx
Thera-P
Helix
EZ Orthopedics
ReLeaf Medical
Elutex
Nasvax
Inca Medical Systems
Eqlibra Medical
Keter Medical
Lartim Medical
Sphinx Tech
CytoD
Active PX
Agamit
Home | About Us | Companies | Investors | News | Newsletter | Copyrights
Design: Asaf Beeri | Dev.: Colours